According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms during the coronavirus disease (COVID-19) pandemic promises a new and improved paradigm—reducing care disparities, while increasing the speed of diagnostic workup.

Flow Chart of Patient Selection


September 9, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms during the coronavirus disease (COVID-19) pandemic promises a new and improved paradigm—reducing care disparities, while increasing the speed of diagnostic workup.

“The immediate-read screening mammography program reduced prior racial and ethnic disparities in same-day diagnostic imaging after abnormal screening mammograms,” wrote first author Brian N. Dontchos, M.D., of Massachusetts General Hospital and Harvard Medical School.

In May 2020, Dontchos et al. implemented a program wherein a dedicated breast imaging radiologist interpreted all screening mammograms in real-time, with patients receiving their results before being discharged. A separate radiologist made efforts to perform any recommended diagnostic imaging during the same visit. The team then retrospectively identified screening mammograms performed from June 1, 2019 to October 31, 2019 (pre-implementation; 8,222 examinations) or June 1, 2020 to October 31, 2020 (post-implementation; 7,235 examinations). 521 and 359 patients had abnormal screening examinations, respectively.

Before implementing this immediate-read screening mammography program, patients with races other than White had lower odds than White patients of having same-day diagnostic imaging after abnormal screening examinations (adjusted odds ratio [OR]: 0.30; 95% confidence interval [CI]: 0.10, 0.86; p=.03). After implementation, these odds were not significantly different (OR: 0.92; 95% CI: 0.50, 1.71; p=.80).

Responding to the Society of Breast Imaging’s recommendation to reduce patient hospital visits during COVID-19, “we believe the practice is sustainable and not limited to only a transient period of lower-than-normal screening volumes,” the authors of this AJR article noted.

For more information: arrs.org

 

Related COVID-19 Cancer-care Information:

Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide

Johns Hopkins Medicine Expert Weighs Devastating Impact of COVID-19 on Healthcare Workers

Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

Breast Imaging in the Age of Coronavirus


Related Content

News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Feature | Radiology Business

The ITN team wishes you a safe and happy 4th of July!

Time July 04, 2024
arrow
News | Breast Imaging

July 2, 2024 — Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue Breast ...

Time July 02, 2024
arrow
News | Artificial Intelligence

June 27, 2024 — Clarius Mobile Health, which provides high-definition handheld ultrasound systems, has obtained U.S ...

Time June 27, 2024
arrow
News | Artificial Intelligence

June 26, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced it ...

Time June 26, 2024
arrow
Subscribe Now